Decreased connexin gene expression and loss of the capacity for either homologous or heterologous intercellular communication has been associated with neoplastic transformation. We tested the hypothesis that loss of gap junctional intercellular communication (GJIC) correlates with tumorigenic potential in the HeLaϫskin fibroblast human hybrid cell system. Connexin gene expression, gap junction function and tumorigenicity were determined for the nontumorigenic somatic hybrid cell line (CGL1) and a series of UVC-induced tumorigenic cell lines derived from CGL1. CGL1 and the parental skin fibroblasts express connexin43 (α1 gap junction gene) mRNA and protein, form gap junctional plaques and have functional gap junctions. UVCirradiation of CGL1 cells produced a cell line (UV12) with an aggressive tumorigenic phenotype, which lost connexin43 expression as well as both homologous and heterologous GJIC and was in this respect similar to HeLa cells. However, the phenotype of UV12 cells exhibited some instability and revertants to a less aggressive tumorigenic phenotype were isolated. These cells expressed connexin43 mRNA and protein, and demonstrated homologous GJIC. Furthermore, cells reconstituted from a tumor derived from this revertant cell line retained significant connexin43 expression and homologous GJIC, although they exhibited an aggressive tumorigenic phenotype. Thus, functional homologous GJIC cannot be dissociated from tumorigenicity in this system. However, heterologous GJIC between these same UVC-induced tumorigenic cell lines and normal human skin fibroblasts was reduced, whereas the nontumorigenic hybrid cells showed extensive heterologous GJIC. In summary, re-acquisition of connexin43 expression and homologous GJIC does not restore the non-tumorigenic phenotype in UVC-induced tumorigenic HeLa skin fibroblast human hybrid cells. However, reduction of heterologous GJIC does correlate with tumorigenicity in this cell system.
Introduction
The initiation and progression of cancer results from multiple alterations involving the activation of cellular proto-oncogenes and the inactivation tumor suppressor genes (1) (2) (3) . These genes regulate cell growth. One family of genes believed to be involved in the control of cell growth are the connexins (4, 5) , which encode for gap junction channels and mediate direct communication between neighboring cells (6, 7) . There is evidence that cell-to-cell communication through gap junctions can have a tumor suppressive function and that connexins may be a special class of tumor suppressor genes. Loss of intercellular communication through gap junctions (GJIC) often accompanies neoplastic growth and restoration of GJIC between normal and neoplastic cells correlates with inhibition of the proliferation of neoplastic cells (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Furthermore, agents that act as tumor promoters inhibit intercellular communication (19) (20) (21) and treatments that increase expression of gap junction proteins reduce tumorigenic potential (22, 23) . Comparisons of cDNA from normal and tumor-derived human mammary epithelial cells in subtractive hybridization experiments have identified a gene encoding for a gap junction protein as a candidate tumor-suppressor gene (24). In addition, transfection of communication deficient transformed cells with connexin cDNA results in re-expression of GJIC, decreased tumor size and increased latencies before onset of exponential growth (25) (26) (27) (28) . These data create a strong presumption that changes in intercellular communication are linked to neoplastic transformation.
Reduced GJIC can be a consequence of mutations of the connexin gene, aberrant channel assembly, and modulation of channel function could block intercellular communication (5) . Thus, both genetic and epigenetic mechanisms may influence GJIC. The role of epigenetic phenomena in cancer development is a subject of some controversy, yet for which there exists strong evidence (29) . Whereas the genetic basis of neoplastic transformation presupposes a mutational event, epigenetics assumes a loss of control involved in normal differentiation and how it is affected by physiological constraints on growth and metabolism. Intimately involved in both genetic and epigenetic processes is the phenomenon of genomic instability. Indeed it has been argued that an early step in tumor progression is the induction of a mutator phenotype, which results in genetic instability (30) . This in turn can result in adaptive responses that are also part of the carcinogenic process (31) .
There is considerable evidence for a role for epigenetic phenomena in the radiation-induced neoplastic transformation of cells in vitro (29) . We have utilized the HeLaϫskin fibroblast human hybrid cell system to study radiation-induced neoplastic transformation and have recently published the observation of reversion of UVC-induced tumorigenic hybrid lines to a less aggressive, and in one instance non-tumorigenic, phenotype (32) . It was hypothesized that this reversion was most likely the result of an epigenetic process. The HeLaϫskin fibroblast cell system is well suited to in vitro studies of neoplastic transformation since it has a unique marker for this endpoint in the expression of the HeLa tumor-associated antigen, intestinal alkaline phosphatase (IAP) (33) , and a specific molecular target in the putative HeLa tumor suppressor gene located on chromosome 11 (34) . It is currently the only human-derived cell system available for detailed quantitative studies of transformation from the non-tumorigenic to the tumorigenic phenotype (35) .
The role of GJIC in the neoplastic transformation of these hybrid cells has not been studied in detail. There is evidence for loss of homologous coupling in a spontaneously arising tumorigenic segregant and this was associated with loss of expression of connexin43 at the mRNA and protein levels (36) . In the present study we have examined the status of homologous and heterologous GJIC in a UVC-induced tumorigenic HeLaϫskin fibroblast cell line, as well as its revertants with less aggressive tumorigenic phenotypes. In addition, we have examined expression of connexin43 at the mRNA and protein levels. The results demonstrate that reversion to the less aggressive tumorigenic phenotype is associated with re-expression of connexin43 and re-acquisition of homologous, but not heterologous, GJIC. These findings are discussed in terms of the association between tumor suppressor function and cell-to-cell communication through gap junctions.
Materials and methods

Cell lines and culture conditions
The normal human fibroblast line, GM00077, and the HeLa/D98-AH2 cell line were obtained from NIGMS Human Genetic Mutant Cell Repository (Coriell Institute for Medical Research, Camden, NJ). The non-tumorigenic HeLaϫskin fibroblast human hybrid cell line designated as CGL1 and a spontaneous tumorigenic segregant designated as CGL3 (37) were the kind gift of Dr Eric Stanbridge (University of California, Irvine, CA). CGL1 was derived from the third serial subclone in methylcellulose of the hybrid line ESH5 and is particularly stable against spontaneous transformation to the tumorigenic state (transformation frequency Ͻ10 -5 ). The derivation of the UVC-induced tumorigenic cell line (UV12) from CGL1 and selection of reverse mutants has previously been described in detail (32) . The UV12-RM101-0R cell line was reconstituted from a tumor derived from UV12-RM101 cells by standard procedures, details of which have previously been published (39) . Cells were grown in Auto-Pow minimal essential medium supplemented with 5% calf serum, 2 mM L-glutamine, non-essential amino acids, 100 IU/ml penicillin and buffered with 20 mM sodium bicarbonate. Cultures were routinely tested for the presence of mycoplasma (38) . The WB-F344 rat liver epithelial cell line (40) was the kind gift of Dr Xiaojun Guan (Scripps Research Institute, La Jolla, CA) and was used as a positive control for connexin43 protein expression in the western blot and immunostaining experiments.
Tumorigenicity testing
Cell lines of interest were expanded and single cell suspensions were prepared so that the final concentration of cells was 1ϫ10 7 cells/0.2 ml of growth medium. Tumorigenicity of the cell lines was tested by injecting 10 7 cells/site subcutaneously into athymic nu/nu mice on the right and left flanks. Six sites (two per mouse) were injected per cell line. The injection sites were examined twice weekly and the length, width and height of any emerging tumors were measured and tumor volumes calculated. The average volume of all tumor sites was plotted against time after injection and the tumor volume doubling time and the time to reach a volume of 500 mm 3 were determined. Fluorescence recovery after photobleaching (FRAP) GJIC was measured by the technique of FRAP (41) . Cells were plated directly onto experimental chambers and grown to until 80-90% confluent. Cells were incubated in 5 µM of the membrane-permeable dyes, 5,6-carboxyfluorescein diacetate (CFDA) or acetoxy-methoxy calcein (calcein) (Molecular Probes, Eugene, OR). During a 30 min incubation, intracellular esterases cleaved the diacetate ester imparting a negative charge to the dye, thus trapping it within the cell. Following a brief rinse to remove extracellular dye, the cells were transferred to a Bio-Rad (Cambridge, MA) MRC 600 confocal microscope. Macro commands written using the Bio-Rad SOM software package, controlled the beam from a ILT 5000 Argon laser (Ion Technology, Salt Lake City, UT). First, the field was scanned using the 488 nm line of the laser and control fluorescence measured. Then, the laser was focused on a small region (0.25 µm 2 ) of the test cell and pulsed until the dye in that cell was photooxidized (bleached) resulting in a decrease in fluorescence. The fluorescence 2086 of the bleached cell was normalized to the fluorescence of an unbleached reference cell from the same field. Control experiments on neighboring but non-touching cells demonstrated that non-junctional dye transfer is negligible. The diffusion of dye into the test cell from neighboring cells through gap junction channels was monitored as an increase of fluorescence with time. The rate of dye return gives a quantitative estimate of the intercellular communication between the test cell and its neighboring cells. Experiments were also performed to examine heterologous coupling, which in the context of this paper is defined as coupling between non-tumorigenic and tumorigenic cell types. These experiments were performed with mixed cultures of the tumorigenic cell of interest and human diploid skin fibroblasts (GM00077). Cells were plated at relative densities such that the non-tumorigenic cells were in 4-fold excess. Prior to plating, the two cell types were incubated overnight with fluoroscein or Texas red labeled latex beads (Molecular Probes) during which time the cells internalized the beads. Therefore, tumorigenic and normal cells could be unequivocally identified in the mixed cultures. For heterologous FRAP measurements, cells were loaded with calcein as described above and dye transfer between a single photobleached tumorigenic cell and the surrounding normal fibroblasts was determined.
RNA extraction and northern blotting RNA was extracted from confluent cells by a modification of the detergent lysis-phenol-chloroform method (42) . Cells were washed in phosphatebuffered saline (PBS) and lysed on the flasks with NP-40 buffer. Lysates were extracted twice with phenol and once with chloroform and RNA was precipitated with ethanol. Northern blots (20 µg/lane) were run on 1% denaturing agarose gels, blotted to nylon (Nytran, ICN Pharmaceuticals, Costa Mesa, CA), and hybridized to 32 P-labeled cDNA probes as described in the legend to Figure 3 . Connexin43 probe (EcoR1, 1393 bp) from JM109 was a generous gift of Dr Nalin Kumar (Scripps Research Institute, La Jolla, CA). Even loading was confirmed by densitometric scanning (Bio-Rad, Hercules, CA) of a Polaroid photograph of the ethidium bromide stained gel and by hybridization to β-actin (EcoRI-BamH1, 700 bp) from pHF A-3Јut (42) . Blots were washed to a stringency of 1ϫ SSC at 65°C and autoradiographs were exposed to Fuji film (Fisher Scientific, Pittsburgh, PA) at -80°C for 1-7 days.
Western analysis
Protein isolation and western blotting were performed by a modification of the methods of Ruch et al. (43) . Briefly, cells were grown to 80-90% confluence, scraped in buffer A (10 mM Tris, pH 7.5, 1 mM iodoacetamide, and 2 mM phenylmethylsulfonyfluoride), alkalinized with NaOH and lysed by passage through 18-and 27-gauge needles. Cell lysates were spun at 100 000 g and pellets resuspended in 200 µl buffer A with 2% SDS. Protein concentration was determined by the Bio-Rad assay (Bio-Rad, Richmond, CA). Samples were electrophoresed on 12% SDS-PAGE minigel with 4.5% stacking gel and blotted to nitrocellulose filters. Connexin43 was detected using a 1:1000 dilution of a rabbit polyclonal antibody (Zymed, South San Francisco, CA) against connexin43, followed by incubation with a 1:500 dilution of a peroxidase-labeled goat anti-rabbit IgG antibody (Zymed) and visualized using the Luminol Chemiluminescence Detection system (Amersham, Arlington Heights, IL) according to the manufacturer's directions.
Connexin43 immunostaining
Cells were grown on cover-slip chambers to 80-90% confluence. At room temperature, cells were rinsed with 3 ml PBS and fixed with 2% paraformaldehyde, pH 7.2 for 15 min. Again at room temperature, cell membranes were permeabilized with 1% Triton X-100 in PBS for 10 min followed by rinsing with 3 ml 0.3% Tween-20-PBS containing 1% rabbit serum (TPBS-RS). Cells were then incubated at room temperature with a 1:500 dilution of rabbit anti-human connexin43 peptide antibody (Zymed Laboratories) or an isotypic control IgG antibody (PharMingen, San Diego, CA) in TPBS-RS for 1 h in a humidified chamber. Cells were then rinsed with 3 ml TPBS-RS and incubated with a 1:200 dilution of a rhodamine-labeled anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) at room temperature in the dark and in a humidified chamber in TPBS-RS for 1 h then rinsed again with 3 ml TPBS-RS. Indirect immunofluorescence was visualized on a MRC 600 confocal microscope (BioRad, Hercules, CA)
Results
Homologous GJIC
The technique of FRAP was used to examine homologous GJIC in CGL1, a non-tumorigenic HeLaϫskin fibroblast cell line; CGL3, a spontaneous tumorigenic segregant from CGL1; UV12, a single cell-derived tumorigenic cell line isolated from UVC-irradiated CGL1 cells; UV12-RM1, a tumorigenic cell line derived from a colony of UV12 cells that had reverted to a morphology similar to that of CGL1; UV12-RM101, a tumorigenic single cell-derived cell line from UV12-RM1; and UV12-RM101-0R, a cell line derived from the reconstitution of a tumor grown in a nude mouse following injection of UV12-RM101 cells. In addition, the parent cell lines from which CGL1 was created, HeLa/D98-AH2 and the human skin fibroblast line GM00077, were also examined for homologous GJIC. Figure 1 shows pseudocolor images obtained from a FRAP study of CGL1 and UV12. The images show the photobleaching of the dye within a single cell followed by nearly complete recovery of dye in the CGL1 cell and an absence of recovery in the UV12 cell during the 10 min intervals post-bleaching. The data in Figure 2 illustrate the recovery kinetics from representative cells from all cell lines examined. Table I summarizes these data for all experiments together with data on the tumorigenic properties of the cell 2087 lines. It can be seen that the aggressively tumorigenic (all injected sites positive for tumor formation and short delay before onset of exponential tumor growth) cell lines HeLa, CGL3 and UV12, all showed loss of homologous communication. On the other hand, the cell line UV12-RM1, and its single cell clone UV12-RM101, which had reverted to a less aggressive tumorigenic phenotype (four of six sites positive and long growth delay) demonstrated re-acquisition of homologous communication with a rate of fluoresence recovery that was essentially the same CGL1 and GM00077 as indicated by the time constants shown in Table I . However, we were surprised to find that the tumor reconstituted cell line, UV12-RM101-0R, retained homologous communication even after having acquired an aggressive tumorigenic phenotype. Moreover, the time constant for recovery indicated more efficient GJIC than CGL1 or GM00077.
Connexin43 expression at the mRNA level
Connexin43 is the only connexin known to be expressed in human skin fibroblasts (36) and no known connexins are expressed in HeLa cells (27, 44) . The expression of connexin43 at the mRNA level was therefore examined in all the cell lines under study. The results are shown in Figure 3a . It can be seen that connexin43 was expressed in the parent skin fibroblast cell line but not the tumorigenic HeLa cell line. The nontumorigenic hybrid cell line CGL1 expressed connexin43, albeit at a reduced level, whereas the tumorigenic cell lines CGL3 and UV12 did not express connexin43. The reverse mutant cell line, UV12-RM1, re-acquired connexin43 expression as did UV12-RM101. Interestingly, the tumor reconstitute UV12-RM101-0R, which has an aggressive tumorigenic phenotype and a capacity for homologous GJIC, showed 4-fold greater connexin43 expression at the mRNA level than either UV12-RM1 or UV12-RM101.
Connexin43 expression at the protein level
While knowledge of connexin43 expression at the mRNA level is of value, it is expression at the protein level that is more relevant in terms of correlation with functional measurements of intercellular communication. We have, therefore, examined connexin43 protein expression using two approaches: western analysis of isolated membrane protein fraction and direct immunostaining of the intact cells. Figure 3b shows the data from western analysis and it can be seen that the expression pattern seen at the RNA level is repeated at the protein level. When corrected for loading, the human skin fibroblasts and the positive control cell line WB-F344 both express considerably more protein than the hybrid cells. Figure 4 shows micrographs illustrating immunofluorescent staining of cell monolayers. Consistent with the results from the western analysis, WB-F344 cells demonstrated the most intense punctate staining while HeLa and UV12 demonstrated no detectable staining above background. CGL1, UV12-RM1, UV12-RM101 and UV-12RM101-0R all demonstrated punctate staining consistent with their ability to demonstrate homologous coupling.
Heterologous GJIC
The data described in the sections above indicate that some tumorigenic HeLaϫskin fibroblast human hybrid cell lines can exhibit functional homologous GJIC and this correlates with expression of connexin43 at the mRNA and protein levels. These are the revertants that have acquired a less aggressive tumorigenic phenotype. However, the tumor reconstitute Fig. 2 . Representative examples of the recovery kinetics for each of the cell lines. GJIC was quantified by digital analysis of the fluorescence intensity. The mean intensity averaged across the cell was plotted for each sampled cell before the application of the laser 'bleaching pulse' (d) and as a function of time following the pulse (s). Data are corrected for loss of dye or photobleaching of a reference cell, which was at least three cells away from the bleached cell. Where fluorescence recovery was observed, the time-course of recovery fitted a single exponential (dotted line) of the form I ϭ I ss -∆I e -t/τ where I is the fluorescent intensity at time t, I ss is the fully recovered fluorescent intensity, τ is the time constant of recovery and ∆I is the difference in intensity of the targeted cell immediately after the laser pulse and I ss . The percent recovery of fluorescence measured 10 min after a photobleaching and the time constant (τ) of recovery are presented as means Ϯ SD (no. of cells). The % and τ recovery for each cell line during homologous or heterologous GJIC were compared against % and τ recovery obtained for homologous GJIC in the parental GM00077 human skin fibroblasts. *Values of P ഛ 0.05 as determined by an ANOVA and a Dunnett's test were considered significantly different. UV12-RM101-0R has an aggressive tumorigenic phenotype yet still shows homologous GJIC and connexin43 expression. It is, therefore, clear that loss of homologous GJIC is not a good marker for the tumorigenic phenotype in these cells. We, therefore, decided to explore heterologous communication in these cells by using mixed cultures of the hybrid cells with human skin fibroblasts. Figure 5 shows examples of either CGL1 or tumorigenic cells surrounded by normal skin fibroblasts and kinetic analyses from typical FRAP experiments. The complete data on heterologous communication are summarized in Table I . It can be seen that heterologous coupling is much less prominent in the tumorigenic cells. Whereas the data indicate low levels of heterogeneity in these measurements, essentially all the tumorigenic cell lines lack heterologous coupling except UV12-RM101, which also happens to be the cell line with the weakest tumorigenic phenotype. Although UV12-RM101 is a cell line derived from a single cell clone, cultures included cells that showed no communication competence, whereas others did communicate. However, those that did communicate did so with lower efficiency than the non-tumorigenic cells as evidenced by the time constants in Table I. 2089
Discussion
In HeLaϫskin fibroblast human hybrid cells, loss of both heterologous and homologous GJIC, as well as the loss of expression of connexin43 can accompany the acquisition of the tumorigenic phenotype. The UVC-induced cell line, UV12, and the spontaneous tumorigenic segregant, CGL3, both exhibited these characteristics. This observation is consistent with the well-described notion that loss of GJIC is either a cause or consequence of neoplastic transformation. However, the data obtained with the colony-derived morphologic revertant UV12-RM1, which has a weak tumorigenic phenotype, demonstrated re-acquisition of functional homologous GJIC as well as re-expression of connexin43 at the mRNA and protein levels. Similar findings were obtained with a single cellderived clone of UV12-RM1, UV12-RM101. These results are consistent with the limited suppression of tumorigenicity of HeLa cells by connexin43 transfection (27) . In addition, the presence of functional communication and connexin43 expression does not necessarily correlate with a weak tumorigenic phenotype as is evidenced by our study with UV12-RM101-0R, which is a cell line reconstituted from a tumor and has an aggressive tumorigenic phenotype similar to UV12 and CGL3. The fact that this tumor-reconstituted cell line grew rapidly in vivo is not surprising, and is most likely a consequence of selection for an aggressive tumorigenic phenotype during the first passage of these cells through a mouse. What is revealing is that this selection for an aggressive tumorigenic phenotype can take place independently of any changes in homologous GJIC. Thus, at least in this cell system, homologous communication, in addition to not being a good marker of tumorigenicity, is also not a good marker for the tumorigenic phenotype. Homologous communication has also been observed between other transformed cells (reviewed in ref. 20) . Thus, competent homologous communication does not correlate with lack of tumorigenicity. However, as pointed out by Loewenstein (4), detection of GJIC does not mean that the cells can successfully communicate a growth control signal. For example, the loss of the ability to produce or respond to a signaling molecule would eliminate growth control in the presence of functioning gap junctions. Additionally, one must consider the possibility that in the tumorigenic cells, the gap junction channels may more efficiently transfer the dyes used for the GJIC measurements than the growth control signal. Finally, according to the GJIC-mediated growth control hypothesis, it is not coupling between transformed cells that is relevant to tumor suppression, but rather communication between the transformed cells and the surrounding non-transformed cells that inhibits tumor growth.
In view of our finding that homologous communication was not a good marker of tumorigenicity we then examined the ability of our tumorigenic cell lines to communicate with nontumorigenic cells, i.e. heterologous communication. For these studies we chose to use diploid human skin fibroblasts as our non-tumorigenic cell. The only hybrid cell line that showed strong heterologous communication in this setting was the non-tumorigenic parent hybrid cell line, CGL1. None of the tumorigenic cell lines was as effective in heterologous communication as the non-tumorigenic cells. In the case of the weakly tumorigenic cell line, UV12-RM101, some cells tested did show heterologous coupling, but with a much reduced rate of dye transfer (Table I) . Differential homologous and heterologous GJIC has been reported in other transformed cells and suggests the formation of unique communication pathways during neoplastic transformation (45) (46) (47) (48) . For the 2090 human hybrid (HeLaϫskin fibroblast) cells used in this study, this observation is of further interest in that both the hybrid cell lines and the skin fibroblast cell line express connexin43. How can they show competent homologous and incompetent heterologous communication when the same connexin is being expressed in both circumstances? This observation is explicable if gap junction formation between the tumorigenic hybrids and the fibroblasts were impaired, perhaps because of changes in expression of necessary cell adhesion molecules in the tumorigenic cells (49) . Alternately, mutation in the extracellular binding domains of Cx43 or changes in protein glycosylation patterns may account for selective communication between transformed cells (47, 48) . Further experiments will be required to determine if alterations in these processes play a role in GJIC between the UV-irradiated cell lines.
Since connexins have been proposed as tumor suppressors, it is of interest to consider the observations presented here in light of the use of the HeLaϫskin fibroblast hybrid cell system to study tumor suppressor function. The tumorigenicity of the HeLa cell is suppressed following fusion with a human skin fibroblast. The formation of tumorigenic segregants in cultures of such hybrids, either spontaneously or by radiation induction, is associated with loss of chromosomes 11 and 14 (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) . Re-introduction of a fibroblast chromosome 11 into tumorigenic segregants by microcell transfer results in re-acquisition of the non-tumorigenic phenotype (34) . This provides strong evidence for the role of a tumor suppressor gene located on chromosome 11 in the suppression of the tumorigenicity of HeLa cells. It is clear that this regulator is not connexin43, since connexin43 does not map to chromosomes 11 or 14, but to chromosome 6 (7, 52, 53) . The question then arises could the gene product involved in the regulation of tumorigenicity also be involved in the positive regulation of connexin43? The data we have suggest that this is unlikely in view of the fact that we have cell lines with essentially equal levels of connexin43 expression, which can be tumorigenic (UV12-RM101) or nontumorigenic (CGL1). Of course, this does not rule out the possibility of a common regulator if the gene dosage requirements of the two regulatory pathways are different.
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Finally, it is of interest to consider the findings reported here in terms of the role of epigenetic processes in neoplastic transformation and the dynamic model of neoplastic transformation that we have proposed is operative in this hybrid cell system (32) . It is apparent from our earlier work with this cell system that radiation-induced tumorigenic segregants can display some instability with respect to certain aspects of their phenotype, e.g. morphology, level of expression of the HeLa tumor-associated antigen IAP, tumor growth characteristics and chromosomal status (32, 39, 50) . We now see evidence for similar fluctuations with respect to their GJIC competence.
In summary, re-acquisition of connexin43 expression and homologous GJIC as a consequence of spontaneous reversion does not restore the non-tumorigenic phenotype in HeLaϫskin fibroblast human hybrid cells. This is consistent with results obtained by transfection of connexin43 into HeLa cells (27) . However, tumorigenicity in this cell system did correlate with reduction of heterologous GJIC.
